389 related articles for article (PubMed ID: 7712029)
1. Production of antinociception by peripheral administration of [Lys7]dermorphin, a naturally occurring peptide with high affinity for mu-opioid receptors.
Negri L; Lattanzi R; Melchiorri P
Br J Pharmacol; 1995 Jan; 114(1):57-66. PubMed ID: 7712029
[TBL] [Abstract][Full Text] [Related]
2. Respiratory and cardiovascular effects of the mu-opioid receptor agonist [Lys7]dermorphin in awake rats.
Negri L; Lattanzi R; Tabacco F; Melchiorri P
Br J Pharmacol; 1998 May; 124(2):345-55. PubMed ID: 9641552
[TBL] [Abstract][Full Text] [Related]
3. Dermorphin analog Tyr-D-Arg2-Phe-sarcosine-induced opioid analgesia and respiratory stimulation: the role of mu 1-receptors?
Paakkari P; Paakkari I; Vonhof S; Feuerstein G; Sirén AL
J Pharmacol Exp Ther; 1993 Aug; 266(2):544-50. PubMed ID: 8394909
[TBL] [Abstract][Full Text] [Related]
4. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding.
Negri L; Improta G; Lattanzi R; Potenza RL; Luchetti F; Melchiorri P
Br J Pharmacol; 1995 Dec; 116(7):2931-8. PubMed ID: 8680727
[TBL] [Abstract][Full Text] [Related]
5. Selective antagonism by naloxonazine of antinociception by Tyr-D-Arg-Phe-beta-Ala, a novel dermorphin analogue with high affinity at mu-opioid receptors.
Sakurada S; Takeda S; Sato T; Hayashi T; Yuki M; Kutsuwa M; Tan-No K; Sakurada C; Kisara K; Sakurada T
Eur J Pharmacol; 2000 Apr; 395(2):107-12. PubMed ID: 10794815
[TBL] [Abstract][Full Text] [Related]
6. [Dmt(1)]DALDA is highly selective and potent at mu opioid receptors, but is not cross-tolerant with systemic morphine.
Riba P; Ben Y; Nguyen TM; Furst S; Schiller PW; Lee NM
Curr Med Chem; 2002 Jan; 9(1):31-9. PubMed ID: 11860345
[TBL] [Abstract][Full Text] [Related]
7. Dermorphin-related peptides from the skin of Phyllomedusa bicolor and their amidated analogs activate two mu opioid receptor subtypes that modulate antinociception and catalepsy in the rat.
Negri L; Erspamer GF; Severini C; Potenza RL; Melchiorri P; Erspamer V
Proc Natl Acad Sci U S A; 1992 Aug; 89(15):7203-7. PubMed ID: 1353890
[TBL] [Abstract][Full Text] [Related]
8. The dermorphin peptide family.
Melchiorri P; Negri L
Gen Pharmacol; 1996 Oct; 27(7):1099-107. PubMed ID: 8981054
[TBL] [Abstract][Full Text] [Related]
9. Antinociception and physical dependence produced by [D-Arg2] dermorphin tetrapeptide analogues and morphine in rats.
Chaki K; Kawamura S; Kisara K; Sakurada S; Sakurada T; Sasaki Y; Sato T; Susuki K
Br J Pharmacol; 1988 Sep; 95(1):15-22. PubMed ID: 2905901
[TBL] [Abstract][Full Text] [Related]
10. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
[TBL] [Abstract][Full Text] [Related]
11. Opioid systems in the response to inflammatory pain: sustained blockade suggests role of kappa- but not mu-opioid receptors in the modulation of nociception, behaviour and pathology.
Millan MJ; Colpaert FC
Neuroscience; 1991; 42(2):541-53. PubMed ID: 1654538
[TBL] [Abstract][Full Text] [Related]
12. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological data on dermorphins, a new class of potent opioid peptides from amphibian skin.
Broccardo M; Erspamer V; Falconieri Erspamer G; Improta G; Linari G; Melchiorri P; Montecucchi PC
Br J Pharmacol; 1981 Jul; 73(3):625-31. PubMed ID: 7195758
[TBL] [Abstract][Full Text] [Related]
14. Effects of the intravenous administration of [Lys7]dermorphin on local cerebral glucose utilization in the rat.
Pontieri FE; Lattanzi R; Benincasa D; Cavallari M; Negri L; Orzi F
Eur J Pharmacol; 2006 Aug; 544(1-3):17-20. PubMed ID: 16831415
[TBL] [Abstract][Full Text] [Related]
15. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
Crain SM; Shen KF
Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
[TBL] [Abstract][Full Text] [Related]
16. Comparison of opioid activity between a N-terminal tetrapeptide analogue of dermorphin, H-Tyr-D-Arg-Phe-beta-Ala-OH and morphine.
Sato T; Takahashi N; Tan-No K; Kisara K; Sakurada T; Sakurada S
Methods Find Exp Clin Pharmacol; 1998 Sep; 20(7):581-6. PubMed ID: 9819802
[TBL] [Abstract][Full Text] [Related]
17. Cross-tolerance between dermorphin and morphine to analgesia and catalepsy in rats.
Broccardo M; Improta G
Peptides; 1985; 6 Suppl 3():165-9. PubMed ID: 3831961
[TBL] [Abstract][Full Text] [Related]
18. Glycodermorphins: opioid peptides with potent and prolonged analgesic activity and enhanced blood-brain barrier penetration.
Negri L; Lattanzi R; Tabacco F; Scolaro B; Rocchi R
Br J Pharmacol; 1998 Aug; 124(7):1516-22. PubMed ID: 9723966
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the antihyperalgesic action of a novel peripheral mu-opioid receptor agonist--loperamide.
Nozaki-Taguchi N; Yaksh TL
Anesthesiology; 1999 Jan; 90(1):225-34. PubMed ID: 9915332
[TBL] [Abstract][Full Text] [Related]
20. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
